Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
Caitriona Ryan, Alan Menter, Lyn Guenther, et al.
British Journal of Dermatology (2018) Vol. 179, Iss. 4, pp. 844-852
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Kamran Ghoreschi, Anna Balato, Charlotta Enerbäck, et al.
The Lancet (2021) Vol. 397, Iss. 10275, pp. 754-766
Closed Access | Times Cited: 413
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2017)
Open Access | Times Cited: 301
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
José María García Ruiz de Morales, L. Puig, E. Daudén, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 1, pp. 102429-102429
Open Access | Times Cited: 278
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2020)
Open Access | Times Cited: 164
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2021) Vol. 2021, Iss. 12
Open Access | Times Cited: 135
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 109
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 92
2021 European guideline for the management of vulval conditions
W I van der Meijden, M. J. Boffa, Bram ter Harmsel, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 7, pp. 952-972
Closed Access | Times Cited: 90
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Piergiorgio Malagoli, Anna Balato, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 2, pp. e2024052-e2024052
Open Access | Times Cited: 17
Psoriasis in special localizations
Klaudia Dopytalska, Piotr Sobolewski, Agata Błaszczak, et al.
Reumatologia/Rheumatology (2018) Vol. 56, Iss. 6, pp. 392-398
Open Access | Times Cited: 93
Itch: an under‐recognized problem in psoriasis
Boni E. Elewski, Andrew Alexis, Mark Lebwohl, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 8, pp. 1465-1476
Closed Access | Times Cited: 78
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities
Alan Menter, Gerald G. Krueger, So Yeon Paek, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 2, pp. 385-400
Open Access | Times Cited: 61
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
Marco Galluzzo, Mark S. Talamonti, Arnaldo Cioni, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2631-2631
Open Access | Times Cited: 49
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting
Matteo Megna, Luca Potestio, Elisa Camela, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 43
Interactions between neutrophils and T-helper 17 cells
Xinzou Fan, Panyin Shu, Ying Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Anti-IL17 therapies for psoriasis
Annika Silfvast‐Kaiser, So Yeon Paek, Alan Menter
Expert Opinion on Biological Therapy (2018) Vol. 19, Iss. 1, pp. 45-54
Closed Access | Times Cited: 83
Anti IL-17 in psoriasis
Karen Ly, Mary Patricia Smith, Quinn Thibodeaux, et al.
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 11, pp. 1185-1194
Closed Access | Times Cited: 75
Adverse events with IL‐17 and IL‐23 inhibitors for psoriasis and psoriatic arthritis: a systematic review and meta‐analysis of phase III studies
Nikolai Loft, Sofie Vaengebjerg, Anne‐Sofie Halling, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 6, pp. 1151-1160
Closed Access | Times Cited: 74
Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review
Ali Al‐Janabi, Amy C. Foulkes, K.J. Mason, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 7, pp. 1440-1448
Closed Access | Times Cited: 70
Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
Alexander Egeberg, Kyoungah See, Alyssa Garrelts, et al.
BMC Dermatology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 69
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
April W. Armstrong, C. Paul, L. Puig, et al.
Dermatology and Therapy (2019) Vol. 10, Iss. 1, pp. 133-150
Open Access | Times Cited: 58
<p>Inverse Psoriasis: From Diagnosis to Current Treatment Options</p>
Giuseppe Micali, Anna Elisa Verzì, Giorgia Giuffrida, et al.
Clinical Cosmetic and Investigational Dermatology (2020) Vol. Volume 12, pp. 953-959
Open Access | Times Cited: 58
Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24‐week real‐world study
Teppei Hagino, Marina Onda, Hidehisa Saeki, et al.
The Journal of Dermatology (2024)
Closed Access | Times Cited: 8
Treatment of Genital Psoriasis: A Systematic Review
Kristen M. Beck, Eric Yang, Isabelle M. Sanchez, et al.
Dermatology and Therapy (2018) Vol. 8, Iss. 4, pp. 509-525
Open Access | Times Cited: 51
Assessment and Clinical Relevance of Serum IL-19 Levels in Psoriasis and Atopic Dermatitis Using a Sensitive and Specific Novel Immunoassay
Robert J. Konrad, Richard E. Higgs, George H. Rodgers, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top